Deciphering Developmental Epileptic Encephalopathies (DEE): Unravelling the Key Signs
DOI:
https://doi.org/10.19166/med.v13i3.8882Keywords:
Developmental encephalopathy, epileptic encephalopathy, epilepsyAbstract
Background: Epilepsy, a chronic neurological disorder affecting over 50 million people worldwide, is marked by recurrent seizures and loss of consciousness. It is categorized based on EEG features, etiologies, and comorbidities. Developmental Encephalopathy (DE) involves developmental delays and early-onset seizures without causing developmental regression. In contrast, Epileptic Encephalopathy (EE) features severe epilepsy syndromes where frequent seizures result in developmental delays or regression.
Methods: This review explores the clinical definitions, epidemiology, and diagnostic criteria for DE, EE, and DEEs. It covers their etiologies, clinical features, diagnostic methods, and treatment strategies, including genetic, structural, metabolic, and immune-related factors.
Results: DE features developmental impairment with epilepsy, while EE involves severe epilepsy causing cognitive and behavioral dysfunction. DEEs are marked by early-onset severe epilepsy and EEG abnormalities that worsen developmental impairments. Essential diagnostic tools include EEG, neuroimaging, and genetic testing. Effective management requires personalized interventions to control seizures and address cognitive deficits.
Conclusion: DEEs are a complex epilepsy subset with major developmental and cognitive challenges. Early diagnosis and targeted treatments are crucial for improving outcomes. Ongoing research into DEEs' genetic and pathophysiological mechanisms is key to enhancing understanding and management.
References
1. Epilepsy. World Health Organization; 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/epilepsy
2. Minardi C, Minacapelli R, Valastro P, Vasile F, Pitino S, Pavone P, Astuto M, Murabito P. Epilepsy in Children: From Diagnosis to Treatment with Focus on Emergency. J Clin Med. 2019;8(1):39. https://doi.org/10.3390%2Fjcm8010039
3. Giussani G., Cricelli C., Mazzoleni F., Cricelli I., Pasqua A., Pecchioli S., Lapi F., Beghi E. Prevalence and incidence of epilepsy in Italy based on a nationwide database. Neuroepidemiology. 2014;43(3-4):228-232. https://doi.org/10.1159/000368801
4. Cutri”French C, Armstrong D, Saby J, Gorman C, Lane J, Fu C, et al. Comparison of core features in four developmental encephalopathies in the Rett Natural History Study. Annals of Neurology. 2020;88(2):396-406. https://doi.org/10.1002/ana.25797
5. Guerrini R, Conti V, Mantegazza M, Balestrini S, Galanopoulou AS, Benfenati F. Developmental and epileptic encephalopathies: From genetic heterogeneity to phenotypic continuum. Physiological Reviews. 2023;103(1):433-513. https://doi.org/10.1152/physrev.00063.2021
6. Raga S, Specchio N, Rheims S, Wilmshurst JM. Developmental and epileptic encephalopathies: Recognition and approaches to care. Epileptic Disorders. 2021;23(1):40-52. https://doi.org/10.1684/epd.2021.1244
7. Hamdan FF, Myers CT, et al. High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies. Am J Hum Genet. 2017; 101(5):664-685. https://doi.org/10.1016/j.ajhg.2017.09.008
8. Scheffer IE, Liao J. Deciphering the concepts behind “epileptic encephalopathy” and “developmental and epileptic encephalopathy.” European Journal of Paediatric Neurology. 2020;24:11-4. https://doi.org/10.1016/j.ejpn.2019.12.023
9. Specchio N, Curatolo P. Developmental and epileptic encephalopathies: What we do and do not know. Brain. 2021;144(1):32-43. https://doi.org/10.1093/brain/awaa371
10. Jain P, Sharma S, Tripathi M. Diagnosis and management of epileptic encephalopathies in children. Epilepsy Research and Treatment. 2013; 2023(1):1-9. http://dx.doi.org/10.1155/2013/501981
11. Gaillard WD, Chiron C, Helen Cross J, Simon Harvey A, Kuzniecky R, Hertz”Pannier L, et al. Guidelines for imaging infants and children with recent”onset epilepsy. Epilepsia. 2009;50(9):2147-53. https://doi.org/10.1111/j.1528-1167.2009.02075.x
12. Kalser J, Cross JH. The epileptic encephalopathy jungle - from dr west to the concepts of aetiology-related and developmental encephalopathies. Current Opinion in Neurology. 2018;31(2):216-22. https://doi.org/10.1097/wco.0000000000000535
13. Korff CM, Brunklaus A, Zuberi SM. Epileptic activity is a surrogate for an underlying etiology and stopping the activity has a limited impact on developmental outcome. Epilepsia 2015; 56(10):1477-1481. https://doi.org/10.1111/epi.13105
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website). The final published PDF should be used and bibliographic details that credit the publication in this journal should be included.
